The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy

Learn more about:
Related Clinical Trial
Ondansetron Effect on Pain Relief After Laparoscopic Cholecystectomy Different Timing for Early Laparoscopic Cholecystectomy in Acute Calcular Cholecystitis Prognostic Indicators as Provided by the EPIC ClearView WSES International Register of Emergency Surgery Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. Prospective Validation of “Cholecystectomy First” Strategy for Gallstone Migration ONSD According to the Position During Laparoscopy Risk of Umbilical Trocar-site Hernia After SILC Cholecystectomy Versus Conventional Cholecystectomy Drainage or Not for Laparoscopic Cholecystetomy UDCA for Symptomatic Gallstone Disease Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Transvaginal Cholecystectomy Using Endoscopic Assistance Doripenem in the Treatment of Complicated Intra-Abdominal Infections Doripenem in the Treatment of Complicated Intra-Abdominal Infections The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy No Need for Neuromuscular Blockade in Daycase Laparoscopic Surgery Efficacy of Proficiency-based Versus Free Laparoscopic Training in Cholecystectomy on a Virtual Reality Simulator Single Port Access (SPA) Cholecystectomy Versus Standard Laparoscopic Cholecystectomy Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy Evaluation of PC 6 “Neiguan” With Conventional Acupuncture to Prevent PONV After Laparoscopic Cholecystectomy. Role of the Right Portal Pedicle and Rouviere’s Sulcus as an Anatomic Landmark in Laparoscopic Cholecystectomy DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Multi-center Study Laparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection. NOTES-Assisted Laparoscopic Cholecystectomy Surgery EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent Effect of Vitamin C on Postoperative Pain After Laparoscopic Cholecystectomy NOVOsyn® for Trocar Incision After Laparoscopic Appendectomy and Cholecystectomy Fluorescence Cholangiography During Cholecystectomy – a RCT Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA FALCON: a Multicenter Randomized Controlled Trial Cholecystectomy First vs Sequential Common Bile Duct Imaging + Cholecystectomy Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy 3D Versus 4K Laparoscopic Cholecystectomy Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic Cholecystectomy Effect of Modified Stylet Angulation on the Intubation With GlideScope® Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor BDD With UDCA Therapy After Laparoscopic Cholecystectomy Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy Postoperative Pain Results According to Pressure to Form Pneumoperitoneum Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®) Prediction of Postoperative Pain by Injection Pain of Propofol Transient ECG Changes in Patients With Acute Biliary Disease Randomized Control Trial of Intraperitoneal Bupivacaine During Cholecystectomy Establishing Visualization Grading Scale on LESS Cholecystectomy Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department Natural Orifice Transgastric Endoscopic Surgical Removal of the Gallbladder Anesthesia With Propofol, Dexmedetomidine and Lidocaine Infusions for Laparoscopic Cholecystectomy A Clinical Study of Chinese Domestic Surgical Robot Laparoscopic Cholecystectomy: Study of Left Side of Laparoscopic Cholecystectomy Tracheal Intubation in Patient With Semi-rigid Collar Immobilization of the Cervical Spine: A Comparison of Fiberoptic Bronchoscope Assisted With Pentax-airway Scope and Fiberoptic Bronchoscope Alone Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy Effects of Drainage in Laparoscopic Cholecystectomy Observation vs Early Removal of LAMS in EUS Guided Cholecystoenterostomy Study of Pain Perception Between Males and Females Following Laparoscopic Cholecystectomy Drainage is Not Necessary Procedure After Laparoscopic Cholecystectomy Due to Severe Acute Cholecystitis Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain Early Versus Delayed Cholecystectomy If Chronic Gallbladder Diseases Increase the Incidence of PEC Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery Use of Robotics for Cholecystectomy; Retrospective Review of Outcomes, Set Up and Learning Curves Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy — Use in Acute Cholecystitis Sub-Study The Relationship Between Post-ERCP-choledocholithiasis and Gallbladder Status Endoscopic Nasogallbladder Drainage Versus Gallbladder Stenting Before Cholecystecomy Enhanced Recovery in Laparoscopic Cholecystectomy Empirical Antibiotics in Acute Inflammatory Gallbladder Disease Primary EUS-GBD in Patients With Unresectable Malignant Biliary Obstruction and Cystic Duct Orifice Involvement. Laparoscopic Cholecystectomy for Acute Cholecystitis After 72 Hours of Symptoms Bile Aspiration vs Drain in Acute Cholecystitis Interest of Intravenous Cholangiography With Indocyanine Green in the Context of Laparoscopic Cholecystectomy for Grade 1 and 2 Acute Gallstone Cholecystitis Fluorescent Cholangiography During Acute Cholecystitis Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis Trial Is it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder? Percutaneous Transhepatic Cholangiography (PTHC) in Acute Cholecystitis and Clinical Outcomes Acute Cholecystitis – Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy Scoring System in Acute Calculous Cholecystitis Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days? Fast Track Pathway to Accelerated Cholecystectomy Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients Efficacy and Safety of Floseal for the Haemostasis During Laparoscopic Cholecystectomy in Acute Cholecystitis (GLA) Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study Short Term Outcomes of Acute Cholecystitis Managed at a University Hospital Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study. Prospective Trial for Endoscopic Ultrasound Guided Gallbladder Drainage for Acute Cholecystitis in High Risk Patients A Randomized Controlled Trial on EGBD vs PC for Acute Cholecystitis. Magnetic Resonance Cholangiography and Intraoperative Cholangiography in Acute Cholecystitis The Role of Ultrasound in Cholecystitis AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis The Real World of Acute Cholecystitis Functional MRC With Eovist for Acute Cholecystitis FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis

Brief Title

The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy

Official Title

The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy

Brief Summary

      The purpose of this study is to evaluate whether a fluorescent die and a special infrared
      camera can assist with the identification of the important structures during laparoscopic
      cholecystectomy. This finding may assist surgeons to perform laparoscopic cholecystectomy in
      less time and in a safer fashion than standard laparoscopic cholecystectomy.
    

Detailed Description

      The purpose of this study is to evaluate whether systemically injected ICG, when fluorescing
      in response to NIR illumination, can assist with the identification of the CBD (common bile
      duct)during laparoscopic cholecystectomy. This finding may assist surgeons to perform
      laparoscopic cholecystectomy in less time and with less morbidity than standard laparoscopic
      cholecystectomy.It is expected that a successful outcome to such a trial will result in less
      time in the operating room and less morbidity following laparoscopic cholecystectomy.

      Laparoscopic cholecystectomy is indicated for cholecystitis, biliary colic, resolved biliary
      pancreatitis, and symptomatic cholelithiasis. Laparoscopic cholecystectomy involves the
      introduction of surgical instruments through a number (usually 4) of small incisions
      measuring about 5-12 mm each with visual guidance being provided by means of a camera
      attached to an endoscope introduced through a similarly small access port. Laparoscopic
      techniques offer numerous benefits including a decrease in postoperative pain, some
      improvement in time to tolerance of food and return of bowel function, shorter hospital stay
      and more rapid return to normal activity.

      Laparoscopic cholecystectomy is one of the most frequently performed surgical procedures in
      the United States. Iatrogenic bile duct injuries are a serious complication and patients
      undergoing the laparoscopic type of cholecystectomy are at increased risk for this
      complication. To minimize risk of injury, techniques such as "critical view" (dissection and
      visualization of the cystic duct and cystic artery) have been developed. However, adhesions,
      inflammation and anatomical variation can make surgical dissection and identification of
      significant structures difficult. In addition significantly longer operative times are seen
      when attempting to obtain the critical view. Some advocate the routine use of cholangiography
      (IOC) but the national standard of care remains to only perform IOC selectively. IOC requires
      cannulation of the cystic duct, injection of iodinated dye, and fluoroscopy which adds
      significantly to the operative time and morbidity especially in centers where routine IOC is
      not performed.

      The present study will investigate whether the use of NIRF after injection of ICG will make
      identification of the Biliary structures and CBD clearer and decrease the time required to
      dissect out critical structures and perform safe cholecystectomy.

      The SPY® Intraoperative Imaging System is cleared for use in Canada, Japan, Europe and the
      US. SPY was originally developed for applications in cardiac surgery and allows cardiac
      surgeons to visually assess bypass graft quality in real-time while the patient is still in
      the operating room. Subsequently, SPY has received clearance from the FDA for use in plastic
      and reconstructive surgery and in solid organ transplant.

      The SPY Intraoperative Imaging System was originally developed for open surgical procedures
      using ICG, which is an FDA approved drug. ICG is a fluorescent compound, which can be
      administered intravenously or intra-arterially. The dye absorbs light in the near infrared
      (NIR) region at 806 nm, and emits light at a slightly longer wavelength, 830 nm. When
      injected intravenously, ICG rapidly and extensively binds to plasma proteins and is confined
      to the intravascular compartment with minimal leakage into the interstitium under normal
      conditions. ICG is taken up by the liver and then excreted into the biliary system where it
      can be imaged. The SPY System has been the subject of numerous peer reviewed publications
      demonstrating its safety .

      SPY scope, the endoscopic version of SPY, is an endoscopic visible (VIS) NIR imaging system
      consisting of:

        1. An endoscopic light source that provides illumination for visible light imaging and NIR
           fluorescence excitation to the endoscope via a flexible light guide

        2. Rigid endoscopes optimized for illuminating the field of view and transmitting images in
           the visible and NIR spectrum, and

        3. A high definition (HD) endoscopic camera system connected to the endoscope eyepiece and
           acquiring high resolution visible and NIR fluorescence images The ICG (25 mg per vial)
           will be reconstituted according to the manufacturer's instructions using the entire
           contents (10 ml) of the sterile diluent supplied, yielding a 2.5 mg/ml solution of ICG
           or using half of the diluent supplied (5 ml) yielding a 5 mg/ml solution.

      ICG Diagnostic Procedure: 3ml of 2.5 mg/ml solution (Akorn product, US Monograph) The ICG may
      be administered through a peripheral venous access. Based on our prior experience in
      colorectal cases 1.0 ml of a 2.5 mg/ml solution of ICG (flushed with 10 ml saline) will be
      administered.

      Our study will include patients undergoing laparoscopic cholecystectomy for both acute
      cholecystitis and non-acute symptomatic cholelithiasis. The standard operating technique will
      be used for all patients including the critical view technique and fluoroscopic IOC if
      clinically indicated.

      Our primary endpoint will be operative time measured as the time from the beginning of the
      dissection until the gallbladder is separated entirely from the gall bladder fossa.

      Secondary endpoints will be time to identification of structures and safety of the operation.
      Other endpoints such as CBD injury and postop bile leak will be included if identified.
    


Study Type

Interventional


Primary Outcome

Operative Time

Secondary Outcome

 Identification of Structures

Condition

Cholelithiasis

Intervention

Indocyanine Green (ICG)

Study Arms / Comparison Groups

 ICG injection with Spyscope imaging
Description:  Indocyanine Green (ICG)

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Drug

Estimated Enrollment

100

Start Date

January 2011

Completion Date

August 2014

Primary Completion Date

August 2014

Eligibility Criteria

        Inclusion Criteria:

          -  Subject is willing and able to provide an informed consent

          -  Subject is willing and able to comply with the study procedures

          -  Subject speaks English and is able to understand the study procedures

          -  A pregnancy test for women of childbearing potential prior to surgery

          -  Subject is scheduled for laparoscopic cholecystectomy

        Exclusion Criteria:

          -  Subject has uremia, serum creatinine >2.5 mg/dl

          -  Subject has a previous history of adverse reaction or allergy to ICG, iodine,
             shellfish or iodine dyes

          -  Subjects in whom the use of x-ray dye or ICG is contraindicated including development
             of adverse events when previously or presently administered

          -  Subject has any medical condition, which in the judgment of the Investigator and/or
             designee makes the subject a poor candidate for the investigational procedure

          -  Subject is a pregnant or lactating female

          -  Subject is actively participating in another drug, biologic and/or device protocol
      

Gender

All

Ages

18 Years - 65 Years

Accepts Healthy Volunteers

No

Contacts

Danny Sherwinter, MD, , 

Location Countries

United States

Location Countries

United States

Administrative Informations


NCT ID

NCT01424215

Organization ID

10/08/VA01


Responsible Party

Principal Investigator

Study Sponsor

Maimonides Medical Center


Study Sponsor

Danny Sherwinter, MD, Principal Investigator, Maimonides Medical Center


Verification Date

May 2020